MIAMI: Researchers have found that processing speed is the primary limiting factor associated with activity and participation in everyday life among people with multiple sclerosis (MS).

Researchers examined cognitive factors associated with both activity and participation. The study, which included 72 individuals with MS, focused Read More »

DALLAS: A hypertension drug has been shown to block traumatic brain injury (TBI) inflammations caused by liver proteins. TBI has been shown to affect the body as well as the brain in animal studies.

Researchers found that brain injuries produce an inflammatory response, in particular Read More »

PHOENIX: One in three people born this year will develop dementia, according to new figures. Early symptoms include problems with memory and thinking. As the disease progresses, people can experience difficulty with walking, balance and swallowing.

The latest analysis showed 27% of boys born in Read More »

WASHINGTON, D.C.: Allergan and Gedeon Richter have finally secured approval for Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

The drug is a potent dopamine D3/D2 receptor partial agonist atypical antipsychotic.

Clearance was based on a package of clinical data garnered from more Read More »